CANDEL THERAPEUTICS
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
CANDEL THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Therapeutics
Founded:
1999-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Website Url:
http://www.candeltx.com
Total Employee:
11+
Status:
Active
Contact:
6179165445
Email Addresses:
[email protected]
Total Funding:
164.9 M USD
Technology used in webpage:
Domain Not Resolving Microsoft Exchange Online Microsoft Azure DNS GoDaddy DNS Cloudflare Hosting Campaign Monitor Campaign Monitor Widget
Similar Organizations
ACEA Therapeutics
ACEA Therapeutics develops and delivers innovative treatments to improve the lives of patients with life-threatening diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
IRX Therapeutics
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
Link Immunotherapeutics
Link Immunotherapeutics develops therapies with a focus on known cancer targets and bispecific architectures.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
ProCure Treatment Centers
ProCure Treatment Centers develops and operates a network of proton therapy centers in cities of the United States.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Candel Therapeutics
H7 Holdings
H7 Holdings investment in Series C - Candel Therapeutics
Level One Partners
Level One Partners investment in Series C - Candel Therapeutics
Sands Capital Ventures
Sands Capital Ventures investment in Series C - Candel Therapeutics
Northpond Ventures
Northpond Ventures investment in Series C - Candel Therapeutics
PBM Capital Group
PBM Capital Group investment in Series B - Candel Therapeutics
National Securities Corporation
National Securities Corporation investment in Series A - Candel Therapeutics
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Grant - Candel Therapeutics
Key Employee Changes
Official Site Inspections
http://www.candeltx.com Semrush global rank: 4.93 M Semrush visits lastest month: 1.75 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Candel Therapeutics"
About | Candel Therapeutics
Learn about Candel Therapeutics' mission to develop novel viral immunotherapies for cancer patients. Our vision, science, and team.See details»
Investor Relations | Candel Therapeutics, Inc
Jun 23, 2025 The Investor Relations website contains information about Candel Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Candel Therapeutics - Crunchbase Company Profile
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.See details»
Candel Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Jun 28, 2025 For more information about Candel, visit: www.candeltx.com Forward-Looking Statements This press release includes certain disclosures that contain “forward-looking …See details»
Candel Therapeutics - LinkedIn
Candel Therapeutics Biotechnology Research Needham, Massachusetts 9,883 followers An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.See details»
Candel Therapeutics Company Profile | Management and
Find contact information for Candel Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Candel Therapeutics's email format.See details»
Corporate Governance - Candel Therapeutics, Inc
The Investor Relations website contains information about Candel Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Pipeline | Candel Therapeutics
Explore Candel Therapeutics' pipeline of viral immunotherapies. Learn about our clinical-stage candidates for various solid tumors.See details»
Candel Therapeutics - Employees, Contact info, Overview - Wiza
May 1, 2024 View info about Candel Therapeutics (candeltx.com). Candel Therapeutics is a company located in Needham, Massachusetts, United States. Find employees, official …See details»
News Releases - Candel Therapeutics, Inc
May 27, 2025 The Investor Relations website contains information about Candel Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Careers | Candel Therapeutics
Any emails you receive from Candel Therapeutics will show @candeltx.com as the email addresses. We will not ask candidates to purchase anything through us or to provide sensitive identifiable information via email to us.See details»
Candel Therapeutics
Candel Therapeutics: Pioneering viral immunotherapies to transform cancer treatment. Discover our innovative platforms and clinical pipeline.See details»
Candel Therapeutics Receives FDA Regenerative Medicine …
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on …See details»
Candel Therapeutics to Host Investor Conference Call Featuring …
NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on …See details»
Investor FAQs | Candel Therapeutics, Inc - ir.candeltx.com
The Investor Relations website contains information about Candel Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to its …
Jul 15, 2021 Prior to her current role as CEO of Xalud Therapeutics, a clinical stage gene therapy biotechnology company, Dr. Nguyen served as Executive Vice President of …See details»
Events and Presentations | Candel Therapeutics, Inc
Nov 20, 2024 The Investor Relations website contains information about Candel Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Candel Therapeutics Receives EMA Orphan Designation for CAN …
3 days ago NEEDHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company …See details»
Renee Gaeta | Candel Therapeutics
Renee Gaeta currently serves as Chief Financial Officer (CFO) at Eko Devices, a privately held cardiopulmonary digital health company. Before joining Eko, she served as CFO and member …See details»
Diem Nguyen, Ph.D., M.B.A. | Candel Therapeutics
Diem Nguyen has more than 25 years of experience and extensive expertise in the pharmaceutical industry. She is currently the CEO of SIGA Technologies, a public commercial …See details»